Bisphosphonates and other bone-targeted agents in breast cancer

Prevention of bone metastases and management of bone health in early breast cancer

Treatment options for women with early-stage breast cancer have never been better, and the addition of bisphosphonates to adjuvant therapy is a valuable new tool capable of substantially improving clinical out...

Authors: Michael Gnant and Peyman Hadji

Citation: Breast Cancer Research 2010 12:216

Content type: Review Published on: 17 December 2010
- View Full Text
- View PDF
Anti-tumour activity of bisphosphonates in preclinical models of breast cancer

There is increasing evidence of anti-tumour effects of bisphosphonates from pre-clinical studies, supporting a role for these drugs beyond their traditional use in treatment of cancer-induced bone disease. A r...

Authors: Ingunn Holen and Robert E Coleman

Citation: Breast Cancer Research 2010 12:214

Content type: Review Published on: 16 December 2010
- View Full Text
- View PDF